胆汁淤积性肝纤维化的研究进展(2)
[3].陸伦根. 胆汁的分泌、排泄和调节及胆汁淤积发生机制[J]. 临床肝胆病杂志,2011,27( 6) : 570 - 571,580.
[4].Rolo AP , Palmeira CM,Wallace KB.Mit ochondrially mediated synergistic cell killing by bile acids.Biochim Bi ophys Acta , 2003 ,1637(1):127-132.
[5].Nakajima T , Okuda Y, Chisaki K , et al.Bile acids increase intracellular Ca(2+)concentrati on and nitric oxide production in vascular endotheli al cells .Br J Pharm acol , 2000 , 130(7):1457-1467
[6].Keith BD.Ursodeoxycholic acid to inhibit the growth of hepatic meatastases[J]. Med Hypotheses, 2000, 55(5):379- 82.
[7].BEUERS U. Drug insight:Mechanisms and sites of action of ursodeoxycholic acid in cholestasis[J] . Nat Clin Pract Gastroenterol Hepatol,2006,3(6):318-328.
[8].ANSTEE QM,DAY CP.S-adenosylmethionine(SAMe) therapy in liver disease:a review of current evidence and clinical utility[J]. J Hepatol,2012,57(5):1097-1109.
[9].LINDOR KD.Farnesoid X receptor agonists for primary biliary cirrhosis[J].Curr Opin Gastroenterol,2011,27(3):285-288., http://www.100md.com(孟旭 赵泽阳 张梓荣)
[4].Rolo AP , Palmeira CM,Wallace KB.Mit ochondrially mediated synergistic cell killing by bile acids.Biochim Bi ophys Acta , 2003 ,1637(1):127-132.
[5].Nakajima T , Okuda Y, Chisaki K , et al.Bile acids increase intracellular Ca(2+)concentrati on and nitric oxide production in vascular endotheli al cells .Br J Pharm acol , 2000 , 130(7):1457-1467
[6].Keith BD.Ursodeoxycholic acid to inhibit the growth of hepatic meatastases[J]. Med Hypotheses, 2000, 55(5):379- 82.
[7].BEUERS U. Drug insight:Mechanisms and sites of action of ursodeoxycholic acid in cholestasis[J] . Nat Clin Pract Gastroenterol Hepatol,2006,3(6):318-328.
[8].ANSTEE QM,DAY CP.S-adenosylmethionine(SAMe) therapy in liver disease:a review of current evidence and clinical utility[J]. J Hepatol,2012,57(5):1097-1109.
[9].LINDOR KD.Farnesoid X receptor agonists for primary biliary cirrhosis[J].Curr Opin Gastroenterol,2011,27(3):285-288., http://www.100md.com(孟旭 赵泽阳 张梓荣)
参见:首页 > 医疗版 > 疾病专题 > 消化内科 > 肝胆疾病 > 肝硬化 > 肝纤维化